Laurus Labs Limited
SBI Life Insurance now holds a 1.07% stake in Laurus Labs Limited, up from under 1% in the previous quarter, with a holding of 57,90,000 shares.
A research-driven pharmaceutical and biotechnology company specializing in Active Pharmaceutical Ingredients for anti-retroviral, oncology, cardiovascular, and gastroenterology therapies with global leadership positions in select segments. Laurus Labs operates multiple facilities approved by major regulatory agencies including USFDA, WHO-Geneva, EMA, and others. The company provides integrated contract manufacturing and development services to international pharmaceutical innovators across clinical development through commercial production stages.
Joint venture between State Bank of India and BNP Paribas Cardif. Manages over Rs 4.7 lakh crore in total AUM with the flagship SBI Life Equity Fund alone holding over Rs 77,000 crore. One of India's largest private life insurers by AUM, with a multi-cap equity book deployed across ULIP and participating funds.